PHARMACOKINETICS OF FLUCONAZOLE IN VERY-LOW-BIRTH-WEIGHT INFANTS DURING THE 1ST 2 WEEKS OF LIFE

Objective: To find a dose of fluconazole for very low birth weight inf ants during an outbreak of Candida parapsilosis. Methods: Twelve prema ture infants (mean gestational age, 27.4 weeks; mean birth weight, 912 gm) receiving fluconazole prophylactically from the first day of life were enrolled in an open phase I-II pharmacokinetics, safety, and tol erance trial. Up to 5 doses of 6 mg/kg were administered intravenously every 72 hours during the first 2 weeks of life. Pharinacokinetic cha racteristics of fluconazole were determined after the first, third, an d fifth doses. Results: The mean peak and trough concentrations after the 3 doses were 5.5 and 2.6 mug/ml, 12.8 and 4.3 mug/ml, and 10.0 and 2.9 mug/ml (p = 0.0002 and p = 0.07), respectively. The mean fluconaz ole half-lives were 88.6 hours (n = 7), 67.5 hours (n = 9), and 55.2 h ours (n = 4; p = 0.3). The mean total clearance corrected for weight ( CL/kg) was 0.18 ml/min/kg (n = 7), 0.33 ml/min/kg (n = 7), and 0.52 ml /min/kg (n = 4; p = 0.02), and the mean volume of distribution 1.18 L/ kg (n = 7), 1.84 L/kg (n = 7), and 2.25 L/kg (n = 4; p = 0.05). Weight -corrected clearance increased with postnatal age (r = 0.61; p = 0.007 ). Conclusions: With the used fluconazole dose (6 mg/kg every 3 days), the mean serum peak and trough concentrations increased during the fi rst week but decreased during the second week. After the first week we suggest a dose of 6 mg/kg every 2 days, or even daily.